It looks like you are using an older version of Internet Explorer which is not supported. We advise that you update your browser to the latest version of Microsoft Edge, or consider using other browsers such as Chrome, Firefox or Safari.

TALLAL YOUNIS
NOYCIA CHAIR | MBBCH, FRCP (UK)

Dr. Younis is a professor of medicine at Dalhousie University, and a consultant medical oncologist at the Queen Elizabeth II Health Sciences Centre (QE II HSC) in Canada. He received his medical degree from Cairo University in 1992 and an MRCP degree from the United Kingdom in 1998. He completed an internal medicine residency in 2001 at the Columbia University and a medical oncology fellowship in 2003 at the Roswell Park Cancer Institute in the USA.

Dr. Younis clinical practice is devoted to breast cancer, and he is board certified (ABIM) in internal medicine and medical oncology. He is the research director for medical oncology at the QEII HSC, and an editor for “Current Oncology” journal. His research interests involve health services research and health technology assessments in breast cancer.
 

Judge Tallal Younis

JAMIL ASSELAH
MD, MEDICAL ONCOLOGIST

Trained in Algiers and Paris as a medical oncologist, Dr. Asselah completed a 2-year fellowship on phase 1 clinical trials at the Investigation Unit of the Curie Institute Cancer Centre in Paris, France.

In 2008, he joined the Université de Sherbrooke as an Assistant Professor, developing new research protocols in breast cancer and standardizing treatment practices at the Centre Hospitalier Universitaire de Sherbrooke, where he also launched the oncology residency program. 

He joined McGill in 2011 as an Assistant Professor in the Department of Oncology and is now Associate Professor and director of Oncology Undergraduate Medical Education. He is on staff as a medical oncologist at the McGill University Health Centre, where he spearheaded a working group standardizing treatment guidelines for breast cancer. He was the first Site Lead for the Rossy Cancer Network.

Dr. Asselah has been the principal investigator in numerous clinical research protocols, and has been part of several research groups at the Provincial and National level. His research interests include Breast Cancers, Gastrointestinal Cancers, and Cancers of the Head and Neck.
 

Jugde Jamil Asselah

GEOFFREY LIU
MD, FRCP(C), FISPE

Dr. Geoffrey Liu , MD FRCP(C) FISPE is the Alan B. Brown Chair in Molecular Genomics, a thoracic medical oncologist, and Professor of Medicine, Medical Biophysics, Epidemiology, and at the Institute of Medical Science at the University of Toronto and the Dalla Lana School of Public Health. He is Senior Scientist at the Ontario Cancer Institute, and runs the Applied Molecular Pharmacogenomic Profiling and Epidemiological Laboratory (AMPPEL). 

He is a Fellow of the International Society for Pharmacoepidemiology, where he is on the committee for developing real world evidence guidelines for the society. His research interests are in clinical, germline, and somatic pharmacogenomics, secondary resistance patterns in targeted agent therapy, utilizing primary derived xenograft and organdies to identify biomarkers of susceptibility and resistance to targeted agents, routine collection of patient-reported and health utility data, and regulatory grade real world evidence methodology.
 

Judge Geoffrey Liu

BARBARA MELOSKY
MD, FRCP (C )

Barbara Melosky, MD, FRCP(C), is a clinical professor of medicine at the University of British Columbia and a medical oncologist at the BC Cancer Center in Vancouver. She graduated from medical school at the University of Manitoba and completed a residency in internal medicine and a fellowship in oncology at the University of British Columbia. Dr. Melosky specializes in thoracic malignancies.

She is Head of the Lung Tumour Group in the province of British Columbia. 

Dr. Melosky sits on the Executive Lung Site Committee for the Canadian Cancer Trials Group (CCTG). She has chaired the annual Canadian Lung Cancer Conference, attended by over 375 participants, for the last 20 years. She is proud to have started and built the British Columbia Lung Cancer Biobank, which is actively used for research for all interested.
She is published extensively and is considered a national and international expert on thoracic malignancies.
 

Judge Barbara Melosky

PATRICIA TANG
MD, FRCP (C)

 

Dr. Patricia Tang is a medical oncologist at the Tom Baker Cancer Centre and a Clinical Associate Professor at the Cumming School of Medicine, University of Calgary.  She is the Provincial Gastrointestinal Cancer Tumor Group Leader for Alberta and her clinical practice is evenly distributed between breast and gastrointestinal cancers.  She is the Centre Representative to the Canadian Cancer Clinical Trials Group for Calgary, a member of the OICR Clinical Trials Subcommittee, and was awarded the Ralph Meyer Phase III Program Young Investigator Award in 2016.  She is currently a member of the Royal College of Physicians and Surgeons of Canada Nucleus Committee for Medical Oncology.

 

Jugde Patricia Tang

SUKHBINDER DHESY-THIND
MD, FRCP (C)

Dr. Bindi Dhesy-Thind is an Associate Professor and Associate Chair (Education) in the Department of Oncology at McMaster University. She is a medical oncologist at the Juravinski Cancer Centre with a clinical and research interest in breast and gastrointestinal malignancies. She holds a MD from Queen’s University and a MSc in Health Research Methodology from McMaster University where she also completed her Residency and Fellowship training. As Departmental Education Coordinator and former Medical Oncology Residency Program Director, she has worked tirelessly to prioritize education within the cancer program and she is known as an advocate for education. She has received multiple teaching awards in recognition of her dedication to learners. 

She is a proud founding member of the BRIGHT Run supporting breast cancer research in the Hamilton area. Dr. Dhesy-Thind is a Committee Member for the Program in Evidence Based Care - Cancer Care Ontario, Breast Disease Site and has been a leader in developing internationally endorsed clinical practice guidelines.
 

Bindi Dhesy-Thind